csirt@kutim:~/threat-intel/cve/CVE-2024-58091

Katalog CVE

CVSS 5.5 · Medium EPSS 0,21%

Kerentanan NULL Pointer Dereference pada linux kernel. Skor CVSS 3.1 5.5 (Medium) menurut NVD.

Deskripsi (NVD)

In the Linux kernel, the following vulnerability has been resolved: drm/fbdev-dma: Add shadow buffering for deferred I/O DMA areas are not necessarily backed by struct page, so we cannot rely on it for deferred I/O. Allocate a shadow buffer for drivers that require deferred I/O and use it as framebuffer memory. Fixes driver errors about being "Unable to handle kernel NULL pointer dereference at virtual address" or "Unable to handle kernel paging request at virtual address". The patch splits drm_fbdev_dma_driver_fbdev_probe() in an initial allocation, which creates the DMA-backed buffer object, and a tail that sets up the fbdev data structures. There is a tail function for direct memory mappings and a tail function for deferred I/O with the shadow buffer. It is no longer possible to use deferred I/O without shadow buffer. It can be re-added if there exists a reliably test for usable struct page in the allocated DMA-backed buffer object.

Rincian

Terbit di NVD
27 Maret 2025
Terakhir diubah
4 Agustus 2026
Status NVD
Modified
CVSS 3.1
5.5 (Medium), sumber NVD
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-476: NULL Pointer Dereference
EPSS (30 hari)
0,21% peluang dieksploitasi; lebih tinggi dari 10,4% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
linux linux kernel Versi 6.11 hingga sebelum 6.12.36
linux linux kernel Versi 6.13 hingga sebelum 6.13.6
linux linux kernel Versi 6.14 rc1
linux linux kernel Versi 6.14 rc2
linux linux kernel Versi 6.14 rc3
linux linux kernel Versi 6.14 rc4

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.